Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 940-948

  Rashid, Harunor ^a   Inoue, Makoto ^a   Kondo, Saori ^a   Kawashima, Toshiko ^a   Bakoshi, Shiho ^b   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Maruishi Pharmaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRADYKININ; CAPSAICIN; NOCICEPTIN; PROSTACYCLIN; VANILLOID RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREAM; DISEASE MODEL; DRUG MECHANISM; DRUG POTENCY; FOOT PAD; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; MOUSE; NERVE FIBER; NERVE INJURY; NEUROPATHIC PAIN; NEWBORN; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; SCIATIC NERVE; THERMAL STIMULATION; TIME SERIES ANALYSIS;

ANALGESIA; ANIMALS; BRADYKININ; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEAT; HYPERALGESIA; MALE; MICE; NERVE FIBERS; PAIN; PAIN MEASUREMENT; RECEPTORS, DRUG; TRPV CATION CHANNELS;

EID: 0037373066     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.046250     Document Type: Article

References (33)

1. Buck SH and Burks TF (1986) The neuropharmacology of capsaicin: a review of some recent observations. Pharmacol Rev 38:179-226.
2. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
3. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, and Di Marzo V (2001) The vanilloid receptor (VR1)mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77:1660-1663.
4. Dobolyi A, Ueda H, Uchida H, Palkovits M, and Usdin TB (2002) Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci USA 99:1651-1656.
5. Ellison N, Loprinzi CL, Kugler J, Hatfield AK, Miser A, Sloan JA, Wender DB, Rowland KM, Molina R, Cascino TL, et al. (1997) Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol 15:2974-2980.
6. Fitzgerald M (1983) Capsaicin and sensory neurons: a review. Pain 15:109-130.
7. Garrison CJ, Dougherty PM, and Carlton SM (1993) Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801 treated rats. Brain Res 607:205-214.
8. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
9. Hökfelt T, Zhang X, and Wiesenfeld-Hallin Z (1994) Messenger plasticity in primary sensory neurons following axotomy and its functional implication. Trends Neurosci 17:22-30.
10. Holzer P (1991) Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 43:143-201.
11. Hingtgen CM and Vasko MR (1994) Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res 655:51-60.
12. Hiura A and Ishizuka H (1989) Changes in features of degenerating primary sensory neurons with time after capsaicin treatment. Acta Neuropathol 78:35-46.
13. Hudson LJ, Bevan S, Wotherspoon G, Gentry C, Fox A, and Winter J (2001) VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 13:2105-2114.
14. Iguchi S, Miyata Y, Miyake H, Arai Y, Okegawa T, and Kawasaki A (1989) Synthesis of 15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy-6, 9α-nitriloprostaglandin F1 methyl ester (OP-2507), a novel anti-cerebral ischemic agent. Adv Prostaglandin Thromboxane Leukotriene Res 19:670-673.
15. Inoue M, Kobayashi M, Kozaki S, Zimmer A, and Ueda H (1998) Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve ending in mice. Proc Natl Acad Sci USA 95:10949-10953.
16. Inoue M, Shimohira I, Yoshida A, Zimmer A, Takeshima H, Sakurada T, and Ueda H (1999) Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J Pharmacol Exp Ther 291:308-313.
17. Jancsó G, Kiraly E, and Jancso-Gabor A (1977) Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature (Lond) 270:741-743.
18. Jancsó N and Jancsó A (1949) Desensitization of sensory nerve endings (in Hungarian). Kisérletes Orvostudomány 2 (Suppl):15.
19. Lee WT, Sohn MK, Park SH, Ahn SK, Lee JE, and Park KA (2001) Studies on the changes of c-fos protein in spinal cord and neurotransmitter in dorsal root ganglion of the rat with an experimental peripheral neuropathy. Yonsei Med J 42:30-40.
20. Liu L and Simon SA (1996) Similarities and differences in the currents activated by capsaicin, piperine and zingerone in rat trigeminal ganglion cells. J Neurophysiol 76:1858-1869.
21. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, and O'Brien PC (1995) Doubleblind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 62:163-168.
22. Malmberg AB and Basbaum AI (1998) Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76: 215-222.
23. Minami T, Bakoshi S, Nakano H, Mine O, Muratani T, Mori H, and Ito S (2001) The effects of capsaicin cream on prostaglandin-induced allodynia. Anesth Analg 93: 419-423.
24. Pitchford S and Levine JD (1991) Prostaglandins sensitize nociceptors in cell culture. Neurosci Lett 132:105-108.
25. Rashid MH and Ueda H (2002) Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. J Pharmacol Exp Ther 303:226-231.
26. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-211.
27. The Capsaicin Study Group (1991) Treatment of painful diabetic neuropathy with topical capsaicin. A multicentre, double-blind, vehicle-controlled study. Arch Intern Med 151:2225-2229.
28. Turnbull A (1850) Tincture of capsicum as a remedy for chilblains and toothache. Dublin Free Press 1:95-96.
29. Ueda H (1999) In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn J Pharmacol 79:263-268.
30. 2+ influx. Mol Pharmacol 57:108-115.
31. Ueda H, Matsunaga S, Inoue M, Yamamoto Y, and Hazato T (2000) Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine. Peptides 21:1215-1221.
32. Watson CP, Evans RJ, and Watt VR (1988) Post-herpetic neuralgia and topical capsaicin. Pain 33:333-340.
33. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.